The Write-Downs Were Already Known Before Q4 ReportRemember they reported the expected write-down for this quarter on Sep. 8. The $3.3B is just adding the write-downs from the previous quarter reports of the fiscal year. The drop in share price already reflected it. While the EBITDA improved by 25% over last quarter, and that trend shows it's true they will be EBITDA positive in early 2021. Mores Cannabis stores are popping up and overseas global sales will increase. The Price to Book P/B is still only .48 even after this fiscal year $3.3B write-down. Aphria is at P/B of .85. And Aphria most likely needs to do a write-down. Aurora is more attractive than Aphria based on the P/B ratio.